Evidence map›Paper›PMID 32066985›Full record

ArticleNature neuroscience2020

A native function for RAN translation and CGG repeats in regulating fragile X protein synthesis.

Caitlin M Rodriguez, Shannon E Wright, Michael G Kearse, Jill M Haenfler, Brittany N Flores, Yu Liu, Marius F Ifrim, Mary R Glineburg, Amy Krans, Paymaan Jafar-Nejad and 6 more

Open access · greenAbstract read
In one paragraph

Article in Nature neuroscience, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 52 papers.

0numbers the graph read from it
0cells of the map it votes in
52citing papers in PubMed
9.5field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

52 citing papers in PubMed, 76 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Beyond Repetition: The Role of Gray Zone Alleles in the Upregulation ofInternational journal of molecular sciences · 2025
    Article
  11. Article
  12. Review
  13. Article
  14. Cells · 2024
    Review
  15. Review
  16. Article
  17. AAGGG repeat expansions triggerScience advances · 2024
    Article
  18. Article
  19. Epigenetic insights into Fragile X Syndrome.Frontiers in cell and developmental biology · 2024
    Review
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

16 authors at 3 institutions in 1 country.

Caitlin M Rodriguez *Department of Neurology, University of Michigan, Ann Arbor, MI, USA.
Shannon E Wright *Department of Neurology, University of Michigan, Ann Arbor, MI, USA.
Michael G KearseDepartment of Neurology, University of Michigan, Ann Arbor, MI, USA.
Jill M HaenflerDepartment of Neurology, University of Michigan, Ann Arbor, MI, USA.
Brittany N FloresDepartment of Neurology, University of Michigan, Ann Arbor, MI, USA.
Yu LiuDepartment of Neurology, University of Michigan, Ann Arbor, MI, USA.
Marius F IfrimDepartment of Cell Biology, Emory University School of Medicine, Atlanta, GA, USA.
Mary R GlineburgDepartment of Neurology, University of Michigan, Ann Arbor, MI, USA.
Amy KransDepartment of Neurology, University of Michigan, Ann Arbor, MI, USA.
Paymaan Jafar-NejadIonis Pharmaceuticals, Carlsbad, CA, USA.
Michael A SuttonDepartment of Molecular and Integrative Physiology, University of Michigan, Ann Arbor, MI, USA.
Gary J BassellDepartment of Cell Biology, Emory University School of Medicine, Atlanta, GA, USA.ORCID http://orcid.org/0000-0003-2622-0127
Jack M ParentDepartment of Neurology, University of Michigan, Ann Arbor, MI, USA.ORCID http://orcid.org/0000-0002-2972-1528
Frank RigoIonis Pharmaceuticals, Carlsbad, CA, USA.
Sami J BarmadaDepartment of Neurology, University of Michigan, Ann Arbor, MI, USA.ORCID http://orcid.org/0000-0002-9604-968X
Peter K ToddDepartment of Neurology, University of Michigan, Ann Arbor, MI, USA. petertod@umich.edu.ORCID http://orcid.org/0000-0003-4781-6376
University of Michigan · USEmory University · USIonis Pharmaceuticals (United States) · US

Funding

Michigan Alzheimer's Disease Core CenterP30AG053760 · NIA · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI PAULSON, HENRY L · 2016 to 2020
$10.1M
TRAINING IN CLINICAL AND BASIC NEUROSCIENCET32NS007222 · NINDS · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI Henry L Paulson · 1985 to 2026
$8.0M
Hexanucleotide repeat translation in ALS and Frontotemporal DementiaR01NS099280 · NINDS · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI Peter K Todd · 2016 to 2026
$4.9M
CGG repeat associated translation in Fragile X-associated Tremor/Ataxia Syndrome-Diversity SupplementR01NS086810 · NINDS · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI TODD, PETER K · 2014 to 2024
$4.1M
RNA decay in amyotrophic lateral sclerosis and frontotemporal lobar degenerationR01NS097542 · NINDS · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI BARMADA, SAMI · 2016 to 2025
$3.8M
Early Stage Training in the NeurosciencesT32NS076401 · NINDS · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI Carol Fuzeti Elias, LESLIE S. SATIN · 2011 to 2026
$3.1M
Pathogenic Mechanisms in Fragile X Tremor Ataxia SyndromeK08NS069809 · NINDS · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI TODD, PETER K · 2010 to 2014
$877k
Specialized regulation of non-AUG translationK99GM126064 · NIGMS · UNIVERSITY OF PENNSYLVANIA · PI KEARSE, MICHAEL G · 2017 to 2018
$158k
Mechanisms of CGG RAN translation in Fragile X-associated tremor/ataxia syndromeF32NS089124 · NINDS · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI KEARSE, MICHAEL G · 2014 to 2015
$108k
Upstream open reading frames in neuronal function: a singular and genome-wide approachF31NS090883 · NINDS · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI RODRIGUEZ, CAITLIN MARIE · 2014 to 2017
$102k
CGG repeat associated translation in Fragile X gene function and diseaseF31NS113513 · NINDS · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI WRIGHT, SHANNON · 2020 to 2022
$84k
NIA NIH HHS P30 AG053760NIGMS NIH HHS K99 GM126064NINDS NIH HHS F31 NS090883NINDS NIH HHS F31 NS113513NINDS NIH HHS F32 NS089124NINDS NIH HHS K08 NS069809NINDS NIH HHS R01 NS086810NINDS NIH HHS R01 NS097542NINDS NIH HHS R01 NS099280NINDS NIH HHS T32 NS007222NINDS NIH HHS T32 NS076401
6 · The paper itself

Abstract

Repeat-associated non-AUG-initiated translation of expanded CGG repeats (CGG RAN) from the FMR1 5'-leader produces toxic proteins that contribute to neurodegeneration in fragile X-associated tremor/ataxia syndrome. Here we describe how unexpanded CGG repeats and their translation play conserved roles in regulating fragile X protein (FMRP) synthesis. In neurons, CGG RAN acts as an inhibitory upstream open reading frame to suppress basal FMRP production. Activation of mGluR5 receptors enhances FMRP synthesis. This enhancement requires both the CGG repeat and CGG RAN initiation sites. Using non-cleaving antisense oligonucleotides (ASOs), we selectively blocked CGG RAN. This ASO blockade enhanced endogenous FMRP expression in human neurons. In human and rodent neurons, CGG RAN-blocking ASOs suppressed repeat toxicity and prolonged survival. These findings delineate a native function for CGG repeats and RAN translation in regulating basal and activity-dependent FMRP synthesis, and they demonstrate the therapeutic potential of modulating CGG RAN translation in fragile X-associated disorders.

Indexed as

AnimalsCell LineCell SurvivalDNA Repeat ExpansionFemaleFragile X Messenger Ribonucleoprotein 1Fragile X SyndromeInduced Pluripotent Stem CellsMaleMiceNeuronsOligonucleotides, AntisenseProtein BiosynthesisRatsRats, Long-EvansRats, Sprague-DawleyFragile X Messenger Ribonucleoprotein 1GRM5 protein, humanOligonucleotides, AntisenseReceptor, Metabotropic Glutamate 5

Identifiers

PMID32066985
PMCPMC7668390
OpenAlexW3006072134

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.